CDC to invest $ 2.1 billion to improve the safety and quality of health care in the United States
Today, the Biden-Harris administration announced a $ 2.1 billion investment to improve infection prevention and control activities in the public health and healthcare sectors in the United States. The Biden-Harris administration, in conjunction with the Centers for Disease Control and Prevention (CDC), invests US bailout funding to strengthen and equip state, local, and territorial public health departments and other partner organizations the resources needed to better fight infections. in U.S. healthcare facilities, including COVID-19 and other known and emerging infectious diseases.
The funding announced today is a commitment that will allow the United States to expand public health and improve the quality of health care in our country, including addressing inequalities in health care. It will help healthcare workers prevent infections in healthcare settings more effectively, support a rapid response to detect and contain infectious organisms, improve laboratory capacity, and engage in innovation to combat the threats of Infectious diseases. Improvements in infection prevention will span the continuum of health care, including 6,000 hospitals, 15,400 nursing homes and other long-term care facilities, 7,900 dialysis clinics and 4,700 day surgery centers, and will expand to other outpatient care facilities.
This funding will significantly improve the safety and quality of health care provided in the United States during the pandemic and into the future. The funding will provide significant resources to our public health departments and health systems and opportunities to develop innovative strategies to protect every segment of the American population, especially those disproportionately affected by the pandemic, at a time when they are badly affected. “
Rochelle P. Walensky, MD, MPH, CDC Director
Additionally, these investments will help address the rise in hospital-acquired infections, which have increased as U.S. hospitals were inundated with COVID-19, reversing national progress seen before the pandemic.
Over the next 3 years, CDC will distribute $ 1.25 billion out of the total to 64 state, local and territorial health departments to support this work. Initial grants totaling $ 885 million will be made in October 2021 to these jurisdictional health services. The CDC will use the majority of that initial funding in October, $ 500 million, to support a new force in the fight against COVID-19 to protect our most affected population disproportionately:
- State nursing homes and long-term care strike teams. This funding from the CDC, in partnership with the Centers for Medicare & Medicaid Services (CMS), will allow states and other jurisdictional health departments to staff, train and deploy strike teams to assist health facilities. skilled nurses, nursing homes and other care facilities with known or suspected outbreaks of COVID-19. Strike teams will enable jurisdictions to provide surge capacity to facilities for clinical services; address staff shortages in institutions; and strengthen infection prevention and control (IPC) activities to prevent, detect and contain outbreaks, including support for COVID-19 vaccine recalls.
The remaining $ 385 million to be allocated in October 2021 will go to state, local and territorial health departments to strengthen five critical areas:
- Strengthening the State’s capacity to prevent, detect and contain threats of infectious diseases in health facilities: The CDC will provide significant infection prevention and control assistance to public health departments to work with health facilities to improve the quality of health care; strengthen infectious disease prevention and containment interventions to minimize the spread of infections in various health care settings; identify, address and monitor health care disparities and health equity; and increase the capacity to investigate outbreaks of nosocomial infections.
- Laboratory capacity for healthcare: The funds provided will also increase the capacity of national and regional laboratories to carry out surveillance for emerging pathogens in order to better identify patients who are infected or carry threats of infectious diseases, such as antibiotic resistant germs such as “nightmarish bacteria”, Carbapenem Resistant Enterobacteriaceae (CRE) and Candida auris. Throughout the pandemic, there have been outbreaks of antibiotic-resistant pathogens in COVID-19 units and other health facilities.
- Firstline project: The funds will expand efforts to design and implement effective infection prevention and control training and education for frontline health workers, leveraging a unique collaboration of partners health, public health and academia. The Firstline project aims to meet the diverse educational needs of its diverse healthcare workforce; make sure they have the knowledge they need to protect themselves, their colleagues and their patients; and develop training and education that addresses the disparities among the US health workforce. In its first year, the CDC’s Firstline project and its partners developed more than 130 educational products and organized over 200 educational events on infection prevention and control, involving approximately 16,300 healthcare workers from professions ranging from environmental service workers to nurses and physicians. Its infection prevention and control messages have reached millions of people through more than 1,700 social media posts shared through CDC and partner channels.
- National Healthcare Safety Network (NHSN): The CDC will increase data and surveillance through the NHSN to determine where and when infections are occurring in healthcare settings and target IPAC interventions. The funds will support the state’s efforts to improve NHSN data collection from health facilities. This includes state coordination, expanding reporting, and providing greater technical assistance to facilities that report health care quality and preparedness data.
- Antibiotic management: The funds will support analyzes of state data on antibiotic use and implement programs to improve antibiotic prescribing in communities, including addressing health disparities related to use. antibiotics. Despite their ineffectiveness against COVID-19, antibiotics were routinely prescribed to patients during the pandemic, increasing the risk of antibiotic resistance.
In addition to amounts provided to state, local and territorial health departments, $ 880 million will be used over several years to help health partners, academic institutions and other nonprofit partners develop new interventions. prevention and infection prevention and control training capacities, data collection, and technical assistance.
The COVID-19 pandemic has heightened the importance of infection prevention and control in healthcare to keep the American population – especially our most vulnerable people in nursing homes and hospitals – safe and in good health. The year 2020 marked an unprecedented time for healthcare facilities, many of which faced extraordinary circumstances of increasing patient numbers, staffing issues, and other operational changes that may have reduced the number of patients. implementation of normal infection prevention practices. Recent studies have shown a substantial increase in nosocomial infections during the pandemic in central catheter-associated blood infections (CLABSI), catheter-associated urinary tract infections (CAUTI), ventilation-associated events (VAS) and methicillin resistance Staphylococcus aureus (MRSA) bacteremia. The data shows an urgent need to strengthen infection prevention and control capacities and build resilience in healthcare to withstand future pandemics and sustain national progress in prevention.
Centers for Disaster Control and Prevention